CAM
JNJ icon

Cresset Asset Management’s Johnson & Johnson JNJ Stock Holding History

Cresset Asset Management’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.4M Sell
337,210
-25,137
-7% -$5.86M 0.36% 45
2025
Q4 		$75M Buy
362,347
+3,970
+1% +$785K 0.32% 49
2025
Q3 		$66.5M Buy
358,377
+4,079
+1% +$699K 0.29% 55
2025
Q2 		$54.1M Sell
354,298
-36,342
-9% -$5.59M 0.27% 60
2025
Q1 		$64.8M Sell
390,640
-13,620
-3% -$2.13M 0.32% 51
2024
Q4 		$58.5M Sell
404,260
-154,139
-28% -$23.9M 0.28% 55
2024
Q3 		$90.5M Buy
558,399
+7,421
+1% +$1.18M 0.35% 42
2024
Q2 		$80.5M Buy
550,978
+54,848
+11% +$8.16M 0.34% 42
2024
Q1 		$78.5M Buy
496,130
+77,559
+19% +$12.3M 0.38% 38
2023
Q4 		$65.6M Sell
418,571
-28,500
-6% -$4.37M 0.39% 41
2023
Q3 		$69.6M Buy
447,071
+30,233
+7% +$4.99M 0.27% 48
2023
Q2 		$69M Buy
416,838
+307,357
+281% +$49.6M 0.09% 71
2023
Q1 		$17M Buy
109,481
+548
+0.5% +$88.5K 0.34% 53
2022
Q4 		$13.9M Sell
108,933
-44
-0% -$7.6K 0.18% 64
2022
Q3 		$17.8M Sell
108,977
-9,847
-8% -$1.67M 0.23% 51
2022
Q2 		$20.1M Buy
118,824
+6,205
+6% +$1.11M 0.25% 46
2022
Q1 		$20M Sell
112,619
-16,417
-13% -$2.79M 0.21% 49
2021
Q4 		$22.1M Buy
129,036
+7,665
+6% +$1.25M 0.21% 51
2021
Q3 		$19.6M Buy
121,371
+13,757
+13% +$2.35M 0.26% 39
2021
Q2 		$17.7M Buy
107,614
+1,234
+1% +$204K 0.25% 38
2021
Q1 		$17.5M Buy
106,380
+15,741
+17% +$2.55M 0.28% 38
2020
Q4 		$14.3M Sell
90,639
-6,708
-7% -$990K 0.23% 40
2020
Q3 		$14.5M Buy
97,347
+1,013
+1% +$150K 0.27% 37
2020
Q2 		$13.5M Buy
96,334
+24,801
+35% +$3.61M 0.3% 37
2020
Q1 		$9.38M Buy
71,533
+26,231
+58% +$3.72M 0.29% 33
2019
Q4 		$6.61M Buy
45,302
+11,796
+35% +$1.6M 0.18% 46
2019
Q3 		$4.33M Buy
33,506
+3,951
+13% +$521K 0.13% 75
2019
Q2 		$4.12M Buy
29,555
+8,820
+43% +$1.22M 0.13% 81
2019
Q1 		$2.9M Buy
20,735
+5,705
+38% +$764K 0.11% 43
2018
Q4 		$1.94M Buy
+15,030
New +$2.1M 0.12% 43

Other funds holding JNJ

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Cresset Asset Management's JNJ Position: Q1 2026 in Review

Cresset Asset Management reduced its Johnson & Johnson (JNJ) stake by 6.9% in Q1 2026, selling an estimated $5.86M and leaving 337,210 shares worth $82.4M. The position accounts for 0.36% of the portfolio, ranked #45.

Cresset Asset Management first reported a position in JNJ in Q4 2018 and has held it in 30 quarters since. The position peaked at $90.5M in Q3 2024. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Cresset Asset Management held 337,210 shares of Johnson & Johnson worth $82.4M as of Q1 2026.
  • Cresset Asset Management sold 25,137 Johnson & Johnson shares in Q1 2026, an estimated $5.86M.
  • Johnson & Johnson made up 0.36% of Cresset Asset Management's portfolio in Q1 2026, its #45 holding.
  • Cresset Asset Management first reported a position in Johnson & Johnson in Q4 2018 and has held it in 30 quarters since.
  • Cresset Asset Management's Johnson & Johnson position peaked at $90.5M in Q3 2024.
  • 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Cresset Asset Management's 13F filing for Q1 2026, filed 15 May 2026.